From the whole-genome gene profiling of the CGGA cohort, the expression of lncRNA HOXA11-AS has been found to be significantly higher in high-grade glioma samples (WHO grade III/IV) than in low-grade gliomas (WHO grade I/II) [158]. This evidence concerns the gene HOXA11 and central nervous system cancer.